Schroeder Thilo's Form 4 filing
Revolution Medicines, Inc. (RVMD) · filed Mar 29, 2022
- Accession no.
- 0001209191-22-021518
- Filed
- Mar 29, 2022
- Trade date
- Mar 25-28, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $1.06M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schroeder ThiloCIK 0001776412 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 25, 2022 | Common Stock | PPurchaseAcquired | +29,235 | $24.59 | +$718,888.65 | 957,825 | Indirect | |
| Mar 25, 2022 | Common Stock | PPurchaseAcquired | +12,765 | $25.26 | +$322,443.9 | 970,590 | Indirect | |
| Mar 28, 2022 | Common Stock | PPurchaseAcquired | +725 | $24.71 | +$17,914.75 | 971,315 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.